These 3 companies are at 52-week highs: Is there still value to be found?

We take a closer look at the future prospects of Telstra Corporation Ltd (ASX:TLS), Sirtex Medical Limited (ASX:SRX), and Goodman Group (ASX:GMG).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's reporting season, and just as cream always rises to the top, today's article sees another collection of great companies trading at 52-week highs.

It's a pretty big list, with companies like Bendigo and Adelaide Bank Ltd (ASX: BEN), Suncorp Group Ltd (ASX: SUN) and iiNet Limited (ASX: IIN) all featuring prominently.

They're joined by other big names like Domino's Pizza Enterprises Ltd. (ASX: DMP), Caltex Australia Limited (ASX: CTX), and Ardent Leisure Group (ASX: AAD).

Most of these companies have been buoyed by recent impressive results that deserve elaboration (you can find articles on these companies and more at fool.com.au), but due to size constraints I'll be focussing on just three companies today:

Telstra Corporation Ltd (ASX: TLS) – last traded at $5.60, up 8.6% for the year.

Profit after tax rose 14.3% in the latest full-year report, a surprising increase that will leave Telstra owners feeling pretty chuffed about their investment.

However the company told investors it expects flat earnings in FY15, which should present the opportunity to buy in at a better price once the glow of the latest annual report wears off.

Although it doesn't look cheap at current prices, Telstra enjoys huge free cash-flows and has extensive experience buying and growing new business lines, meaning it's definitely not a company to bet against for the long term.

Sirtex Medical Limited (ASX: SRX) – last traded at $20.10, up 49.7% for the year.

Although Sirtex hasn't released its full-year results yet, it did recently reveal that fourth quarter sales doses of its liver cancer therapy rose 27.1% compared to the prior corresponding period. It now has 40 consecutive quarters of sales increases.

Notably, the company expects the trend to continue and will cease reporting quarterly dose increases in favour of focussing on its 2020Vision strategy – a plan to deliver accelerated growth over the medium to long term.

Although it's not cheap by any means, Sirtex is likely to deliver enough growth over the coming years to compensate for the premium you pay on your investment today.

Goodman Group (ASX: GMG) – last traded at $5.34, up 11.3% for the year.

I wrote an article earlier this year entitled '2 blue chip stocks you should own, but probably don't', in which Goodman Group featured prominently.

The company has since paid back my vote of confidence, delivering a 46% increase in revenue and a 10.5% increase in operating profits. Dividends also rose 7.3% for the year.

With a substantial undeveloped land bank in China and a high percentage of foreign income, I think Goodman makes a fair investment for the medium term, even though today's prices are quite high.

Net Tangible Assets are only roughly 50% of the share price which may spook some investors, although gearing is also quite low at 19.5%.

Although all three of these stocks are likely to grow dividends in the future, only one is a truly great dividend stock – Telstra.

However Telstra's dividends aren't growing in size very rapidly, meaning the shrewd investor can often find a better performing company that will pay better dividends than Telstra over the long term.

Our leading analyst has selected one such company as The Motley Fool's Top Dividend Stock for 2014-2015.

With a strong track record of growing earnings and dividends, a purchase now could see you earning progressively greater dividends as the company grows over time.

It's a company I already own, and one I think that you should have a look at too.

If you're interested, simply click on the link below and enter your email address – it takes less than 30 seconds – and we'll send it to you, absolutely FREE!

Motley Fool contributor Sean O'Neill doesn't own shares in any company mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »